“…The importance of experts' opinion based on clinical experience, in the choice of conditions to be screened for is also present in other Southeast countries, as Cambodia and Laos [54][55]. In other countries, such as Singapore [56][57], Thailand [58] and the Philippine [59], the decision to include a particular condition tend to be based on strong evidence demonstrating the effectiveness of screening and the potential benefits to affected individuals and families Changes brought by the technological diagnostic development in the field of neonatal screening, a new understanding of screenable conditions, and new possibilities of treatment, have fueled the expansion of NBS programs around the world [60][61]. However, Vietnam as many other LMICs is not taking part in this trend, but the government has set a specific target according to which, by 2030, 90% of newborns should be screened for at least 5 of the most common congenital diseases in the country: GPD deficiency; congenital hypothyroidism; congenital adrenal hyperplasia, galactose metabolism disorder, and phenylketonuria.…”